Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Neurosurgical Focus
|
January 2, 2015
Survival and low-grade glioma: the emergence of genetic information
Elizabeth B Claus, Kyle M Walsh, John K Wiencke, et al.
Acta Neuropathologica Communications
|
June 4, 2014
A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma
Aurélie Catteau, Hélène Girardi, Florence Monville, et al.
Journal of Neuropathology and Experimental Neurology
|
August 27, 2022
Glioblastoma, IDH-Wildtype Harboring a KIAA1549::BRAF Fusion: Report of a Case With Comprehensive Molecular Profiling
J Franklin Berry, Devan W Vidrine, Antonina A Wojcik, et al.
Neuro-Oncology
|
September 10, 2008
Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131
Michael A Vogelbaum, Brian Berkey, David Peereboom, et al.
The American Journal of Pathology
|
July 9, 2018
Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease
Cristina Beltrami, Kate Simpson, Mark Jesky, et al.
Brain Pathology (Zurich, Switzerland)
|
February 10, 2017
Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation
Rachael A Vaubel, Alissa A Caron, Seiji Yamada, et al.
The American Journal of Pathology
|
June 18, 2013
Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro
Rebecca R Foster, Lynne Armstrong, Siân Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2003
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities
Jan C Buckner, Dean Gesme, Judith R O'Fallon, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 8, 2025
Genomewide association study of a homogeneous multiple sclerosis cohort: Tumefactive demyelination
Hannah H Zhao-Fleming, Paul A Decker, Matthew L Kosel, et al.
The American Journal of Pathology
|
May 13, 2017
miR-21 Promotes Fibrogenesis in Peritoneal Dialysis
Melisa Lopez-Anton, Mark Lambie, Manuel Lopez-Cabrera, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Neurosurgical Focus
|
January 2, 2015
Survival and low-grade glioma: the emergence of genetic information
Elizabeth B Claus, Kyle M Walsh, John K Wiencke, et al.
Acta Neuropathologica Communications
|
June 4, 2014
A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma
Aurélie Catteau, Hélène Girardi, Florence Monville, et al.
Journal of Neuropathology and Experimental Neurology
|
August 27, 2022
Glioblastoma, IDH-Wildtype Harboring a KIAA1549::BRAF Fusion: Report of a Case With Comprehensive Molecular Profiling
J Franklin Berry, Devan W Vidrine, Antonina A Wojcik, et al.
Neuro-Oncology
|
September 10, 2008
Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131
Michael A Vogelbaum, Brian Berkey, David Peereboom, et al.
The American Journal of Pathology
|
July 9, 2018
Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease
Cristina Beltrami, Kate Simpson, Mark Jesky, et al.
Brain Pathology (Zurich, Switzerland)
|
February 10, 2017
Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation
Rachael A Vaubel, Alissa A Caron, Seiji Yamada, et al.
The American Journal of Pathology
|
June 18, 2013
Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro
Rebecca R Foster, Lynne Armstrong, Siân Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2003
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities
Jan C Buckner, Dean Gesme, Judith R O'Fallon, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 8, 2025
Genomewide association study of a homogeneous multiple sclerosis cohort: Tumefactive demyelination
Hannah H Zhao-Fleming, Paul A Decker, Matthew L Kosel, et al.
The American Journal of Pathology
|
May 13, 2017
miR-21 Promotes Fibrogenesis in Peritoneal Dialysis
Melisa Lopez-Anton, Mark Lambie, Manuel Lopez-Cabrera, et al.
Page
of 7